DUBLIN--(BUSINESS WIRE)--The "Global Cell Therapy Market, Price, Product & Clinical Pipeline Outlook 2024" report has been added to ResearchAndMarkets.com's offering.
The report on the Global cell therapy market provides a detailed insight into the current scenario of the cell therapy market worldwide. Key data like pricing of cell therapy products, cost analysis of cell therapy procedures, adoption rate, current market trends and recent developments that might impact the cell therapy market are also highlighted in the report. Further, extensive analysis using data from primary and secondary source has been used for the effective forecast and future projections regarding the cell therapy market.
Stem cell therapy is currently the dominant segment in the cell therapy market with maximum success rate reported globally. Their special ability to differentiate into any type of cell without losing their identity makes them the most promising therapeutic entities of the future. Researchers claim that stem cells are bound to revolutionize regenerative medicine with it being applied in the treatment of complex disease such as cardiovascular disease, neurodegenerative disease, inflammatory disease and cancer.
Moreover, researchers assume that modification of cell therapy techniques could result in potential cures for multiple sclerosis, diabetes, spinal cord injury, cancer, heart disease, Parkinson's disease, Alzheimer's disease, and immune system disorders. The role of cell therapy and stem cell research will also be most helpful in the therapeutic sectors of cloning and regenerative medicine
Cell therapy based products like Kymriah, Provenge and Yescarta have been well received in the market inspite of their hefty price tag; costing well over US$ 100,000 which clearly indicates the lucrative nature of the cell therapy market.
Report Highlights
- Market Analysis by Application in Various Therapeutic Areas
- Comprehensive Insight On Clinical Pipeline: 664 Cell Therapies
- Cell Therapy Market Opportunity More Than US$ 25 Billion by 2024
- Marketed Cell Therapies: 21
- Price & Product Insight By Region/Country
- Cell Therapy Clinical Pipeline Overview
- Collaborations & Acquisition in the Cell Therapy Segment
- Regional Analysis of the Cell Therapy Market
Key Topics Covered
1. Prologue to Cell Therapy
2. Mechanism of Cell Therapy Treatment
3. Stem Cells - Their Application & Contribution in the Establishment of Cell Therapy Market
4. Cell Therapy Market Analysis by Application in Various Therapeutic Areas
5. Product & Price Analysis of Cell Therapy Approved in US
6. Product & Price Analysis of Cell Therapy Products Approved in Europe
7. Product & Price Analysis of Cell Therapy Approved in South Korea
8. Product & Price Analysis of Cell Therapy Approved in Japan
9. Current Status of the Global Cell Therapy Market
10. Global Cell Therapy Market Trends
11. Collaborations & Acquisition in the Cell Therapy Segment
12. Regional Analysis of the Cell Therapy Market
13. Global Cell Therapy Market Dynamics
14. Future Prospectus & Scope of the Cell Therapy Market
15. Global Cell Therapy Clinical Pipeline by Company, Indication & Phase
16. Marketed Cell Therapy Clinical Insight
17. Competitive Landscape
- AlloCure
- Arteriocyte Medical Systems
- Athersys Inc.
- Baxter Healthcare Corporation
- Bone Therapeutics
- Celgene Corporation
- Cell Medica
- Cellerant Therapeutics
- FibrocellScinence
- Forticell Bioscience
- Genzyme Corporation
- Green Cross Cell
- Histogenics Corporation
- InnovacellBiotechnologie AG
- Intrexon Corporation
- Intercytex
- ISTO Technologies
- Macrocure
- Mesoblast
- Molmed
- Nuo Therapeutics Inc
- OmniCyte
- Opexa Therapeutics
- Organogenesis
- Pharmicell
- TCA Cellular Therapy
- Stem Cell Inc.
- Teva Pharmaceuticals
- Tigenix
- Vericel Corporation
For more information about this report visit https://www.researchandmarkets.com/research/q87r9j/global_cell?w=4
